Michael Schmelmer
Directeur Général chez Boehringer Ingelheim Verwaltungs GmbH
Profil
Michael Schmelmer is currently the Co-Managing Director at Anasco GmbH, BIOTHERAX biochemisch-pharmazeutische GmbH, Boehringer Ingelheim Verwaltungs GmbH, Boehringer Ingelheim Auslandsbeteiligungs GmbH, and the Member-Management Board at C.H.
Boehringer Sohn AG & Co. KG.
Postes actifs de Michael Schmelmer
| Sociétés | Poste | Début |
|---|---|---|
Boehringer Ingelheim Verwaltungs GmbH
 Boehringer Ingelheim Verwaltungs GmbH Financial ConglomeratesFinance Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Verwaltungs GmbH is an investment holding German company. The company is based in Ingelheim am Rhein, Germany. The CEOs are Andreas Neumann, Michael Schmelmer. The company was founded in 2007. | Directeur Général | - |
Anasco GmbH /DE/
 Anasco GmbH /DE/ Financial ConglomeratesFinance Anasco GmbH is a company based in Ingelheim am Rhein, Germany. Part of C.H. Boehringer Sohn AG & Co. KG, Anasco GmbH provides investment services. The German company was founded in 1992, and the CEOs are Frank Hübler and Michael Schmelmer. | Directeur Général | 26/01/2018 |
BIOTHERAX biochemisch-pharmazeutische GmbH
 BIOTHERAX biochemisch-pharmazeutische GmbH Pharmaceuticals: MajorHealth Technology BIOTHERAX biochemisch-pharmazeutische GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Michael Schmelmer, Martin Beck. | Directeur Général | - |
C.H. Boehringer Sohn AG & Co. KG
 C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Corporate Officer/Principal | - |
Boehringer Ingelheim Auslandsbeteiligungs GmbH
 Boehringer Ingelheim Auslandsbeteiligungs GmbH MiscellaneousMiscellaneous Boehringer Ingelheim Auslandsbeteiligungs GmbH operates an investment holding company, which through its subsidiaries engages in research, development, manufacture, and sale of pharmaceutical products and animal health care services. The company is headquartered in Ingelheim, Ingelheim. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Boehringer Ingelheim Verwaltungs GmbH
Boehringer Ingelheim Verwaltungs GmbH Financial ConglomeratesFinance Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Verwaltungs GmbH is an investment holding German company. The company is based in Ingelheim am Rhein, Germany. The CEOs are Andreas Neumann, Michael Schmelmer. The company was founded in 2007. | Finance |
Anasco GmbH /DE/
Anasco GmbH /DE/ Financial ConglomeratesFinance Anasco GmbH is a company based in Ingelheim am Rhein, Germany. Part of C.H. Boehringer Sohn AG & Co. KG, Anasco GmbH provides investment services. The German company was founded in 1992, and the CEOs are Frank Hübler and Michael Schmelmer. | Finance |
BIOTHERAX biochemisch-pharmazeutische GmbH
BIOTHERAX biochemisch-pharmazeutische GmbH Pharmaceuticals: MajorHealth Technology BIOTHERAX biochemisch-pharmazeutische GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Michael Schmelmer, Martin Beck. | Health Technology |
C.H. Boehringer Sohn AG & Co. KG
C.H. Boehringer Sohn AG & Co. KG Pharmaceuticals: MajorHealth Technology C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
Boehringer Ingelheim Auslandsbeteiligungs GmbH
Boehringer Ingelheim Auslandsbeteiligungs GmbH MiscellaneousMiscellaneous Boehringer Ingelheim Auslandsbeteiligungs GmbH operates an investment holding company, which through its subsidiaries engages in research, development, manufacture, and sale of pharmaceutical products and animal health care services. The company is headquartered in Ingelheim, Ingelheim. | Miscellaneous |
